Davis Polk advised Leerink Swann LLC as the sole book-running manager in connection with an SEC-registered offering of 2,300,000 shares of common stock of Cardiovascular Systems, Inc. (CSI), including 300,000 shares from the exercise of the underwriters’ over-allotment option. The gross proceeds from the offering were approximately $38 million.

CSI is a medical device company focused on developing and commercializing innovative interventional treatment for vascular disease, including peripheral artery disease and coronary artery disease. CSI is headquartered in St. Paul, Minnesota.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Sara Chang and Jeffrey Hamilton. Associate David R. Bauer provided intellectual property advice. The tax team included partner Rachel D. Kleinberg. Cassandra Aguirre was the legal assistant on the transaction. Members of the Davis Polk team are based in the Menlo Park and New York offices.



Related Posts:

Leave a Reply